Skip to main content

Resource Download
Precision Therapies Without Precision Access: Rethinking CDx Commercialization in Oncology

EPP Life Sciences Pricing Forum 2025 October 29 - 31 | Montreux, Switzerland

  • Fragmented CDx strategies undermine the promise of biomarker-driven innovation in oncology. 
  • Aligning CDx development with affordability goals is key to equitable and sustainable precision care 

EPP Prime+ Required to access this resource

Join EPP Prime+ now and get direct access to the best resources, weekly updated with new content, webinars, dynamic talks, tools from the EPP Community.

Subscribe your team and benefit from important group discounts

EPP Prime+
Back